Parallel Bio a pioneering biotech company focused on leveraging the immune system to combat diseases has introduced its latest innovation the Clinical Trial in a Dish This revolutionary
Voyager Therapeutics Inc a biotech company focused on neurogenetic medicines announced the dosing of the first participants in its Phase a single ascending dose trial of VYTAU
Ocugen Inc a biotechnology company focused on developing novel gene and cell therapies as well as vaccines has announced the completion of dosing in the second cohort of its Phase GARDian clinical trial
Arexvy the worlds first respiratory syncytial virus vaccine has recently gained approval from the Health Sciences Authority of Singapore for immunizing individuals aged years and above against lower respiratory tract disease caused by RSV This groundbreaking achievement underscores GSKs commitment
Ractigen Therapeutics a leading clinicalstage pharmaceutical company dedicated to developing innovative therapies has announced a significant achievement the approval of its Investigational New Drug
Zai Lab Limited has announced that the Center for Drug Evaluation of the China National Medical Products Administration has accepted the supplemental Biologics License Application
Protein Dynamic Solutions this week launched its StateoftheArt ProteinMentor platform technology at the PEGS Boston Summit ProteinMentor consists of a Quantum Cascade Laser
Virios Therapeutics Inc a developmentstage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases including fibromyalgia and LongCOVID
Axonics Inc today announced that it has received regulatory approval from the Therapeutic Goods Administration for marketing the Axonics F rechargefree sacral neuromodulation system in Australia to treat adults with overactive bladder Approval of the Axonics rechargefree system
Oragenics Inc a pioneering pharmaceutical company specializing in intranasal treatments for neurological disorders today announced an update on the company and its drug development program
Glenmark Pharmaceuticals Ltd has received final approval by the United States Food Drug Administration for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution Glenmarks Brimonidine Tartrate
EVQ Bio a whollyowned subsidiary of EVQ Nano today announced the successful completion of a PreInvestigational New Drug meeting with the US Food and Drug Administration
Czech, Republic
Prague, Czech Republic
Berlin, Germany
Boston, MA, USA
Pennsylvania, USA
Boston, MA, USA
BASEL, SWITZERLAND
Sydney‚ Australia
Geneticist and Genetic Counselor, MFC Woman and Child Care, West Bengal, India
Assistant Professor, Department of Zoology; Ramakrishna Mission Vivekananda Centenary College, West Bengal, India
School of Life Sciences, Lanzhou University, Gansu Province, China
Department of Microbiology, Khyber Medical University Peshawar, Pakistan
School of Stomatology, Northwest Minzu University, Lanzhou, Gansu, China
Gansu Public Provincial Hospital, Gansu Province, China
Department of Microbiology, Khyber Medical University Peshawar, Pakistan
School of Life Sciences, Lanzhou University, Gansu Province, China
Lanzhou University Second Hospital, Gansu Province, China
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology
Chemistry Division, School of Advanced Sciences, Vellore Institute of Technology
Department of Chemistry, School of Advanced Sciences, Vellore Institute of Technology
Assistant Professor , Department of Pharmaceutics at L. M. College of Pharmacy
Research Student, Pursuing M. Pharmacy, Pharmaceutics, L. M. College of Pharmacy
Assistant Manager - Medical Affairs and Pharmacovigilance, Unichem Laboratories Ltd.
Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner LygatureNSF remediation experts work to assist companies around the world in their remediation efforts Some projects arise from a client identifying a risk themselves while others are a company responding to a communication from a regulatory agency This article will look at why remediation projects are needed the traits of successful programs and what you need to do to ensure success in your remediation e...
AbstractA simple selective and precise method based on HPTLC has been developed for the simultaneous determination of aliskiren and hydrochlorothiazide in a fixeddose tablet formulation and human plasma The chromatography was performed on silica gel GF plates with a mobile phase consisting of methanolchloroform vv Densitometric analys
AbstractOne of the major challenges in the medical domain today is how to exploit the huge amount of data that this field generates To do this approaches are required that are capable of discovering knowledge that is useful for decision making in the medical field Time series are data types that are common in the medical domain and require specialized analy
AB Sciex LLC has introduced a groundbreaking technology solution the CESIMS that allows biopharmaceutical scientists to test efficacy lessen the time to market new therapeutics and quickly detect potential issuesCESI is a unique combination of Capillary Electrophoresis CE and Electrospray Ionization ESI technologies to create an integrated workflow solution which is
Early phase clinical trials have their own unique challenges as they play a vital role in drug development During early trials we aim to evaluate the safety tolerability
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster